Evaluation of the PCA3 Score to guide biopsy decision in an Austrian cohort
← back
Evaluation of the PCA3 Score to guide biopsy decision in an Austrian cohort
Reviewed by: Ismar HealthcareThis poster was presented by Remzi M at the World Congress of Controversies in Urology (CURy) meeting, 31 January -3 February 2008, Barcelona, Spain
- Keywords:
- Prostate cancer
- PCA3 Score
- Repeat biopsy
- Risk
- Specificity
- HGPIN